You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drug Sales Trends for GENTAMICIN

✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for GENTAMICIN (2021)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$412,596
INSIDE ANOTHER STORE	$1,885,563
[disabled in preview]	$2,097,026
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	7,168
INSIDE ANOTHER STORE	32,038
[disabled in preview]	53,962
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$206,937
MEDICARE	$683,890
[disabled in preview]	$3,504,358
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for GENTAMICIN

Drug Units Sold Trends for GENTAMICIN

Annual Sales Revenues and Units Sold for GENTAMICIN

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Subscribe
Drug Name	Revenues (USD)	Units	Year
GENTAMICIN	⤷ Subscribe	⤷ Subscribe	2021
GENTAMICIN	⤷ Subscribe	⤷ Subscribe	2020
GENTAMICIN	⤷ Subscribe	⤷ Subscribe	2019
GENTAMICIN	⤷ Subscribe	⤷ Subscribe	2018
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.